相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
Susan C. Williams et al.
ACTA NEUROPATHOLOGICA (2011)
Mutant IDH1 Confers an in Vivo Growth in a Melanoma Cell Line with BRAF Mutation
Tatsuhiro Shibata et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites
Melissa B. Pappalardi et al.
BIOCHEMICAL JOURNAL (2011)
Gone FISHing: Clinical Lessons Learned in Brain Tumor Molecular Diagnostics over the Last Decade
Craig Horbinski et al.
BRAIN PATHOLOGY (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group
Ian F. Pollack et al.
CHILDS NERVOUS SYSTEM (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Isocitrate Dehydrogenase Mutations: A Challenge to Traditional Views on the Genesis and Malignant Progression of Gliomas
Michael Weller et al.
GLIA (2011)
Molecular signatures classify astrocytic gliomas by IDH1 mutation status
Grischa Toedt et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
Brock C. Christensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
Nanne K. Kloosterhof et al.
LANCET ONCOLOGY (2011)
Scientific correspondence
S. Pusch et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations
Genglin Jin et al.
PLOS ONE (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view
David Basanta et al.
PHYSICAL BIOLOGY (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes
Marcel Seiz et al.
ACTA NEUROPATHOLOGICA (2010)
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2010)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Philippe Metellus et al.
ACTA NEUROPATHOLOGICA (2010)
IDH1R132 mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain
Giselle Y. Lopez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
Avaniyapuram Kannan Murugan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
David Capper et al.
BRAIN PATHOLOGY (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
Meghan J. Seltzer et al.
CANCER RESEARCH (2010)
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J. van den Bent et al.
CLINICAL CANCER RESEARCH (2010)
Segregation of Non-p.R132H Mutations in IDH1 in Distinct Molecular Subtypes of Glioma
Lonneke A. M. Gravendeel et al.
HUMAN MUTATION (2010)
Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 alpha Enhances Hypoxic Gene Expression and Tumor Growth
Adam J. Krieg et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Upregulation of cytosolic NADP+-dependent isocitrate dehydrogenase by hyperglycemia protects renal cells against oxidative stress
Soh-Hyun Lee et al.
MOLECULES AND CELLS (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
M. Labussiere et al.
NEUROLOGY (2010)
Cancer-associated IDH mutations: biomarker and therapeutic opportunities
K. E. Yen et al.
ONCOGENE (2010)
IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria
Martijn Kranendijk et al.
SCIENCE (2010)
IDH mutations in glioma and acute myeloid leukemia
Lenny Dang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome
Takuya Watanabe et al.
ACTA NEUROPATHOLOGICA (2009)
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2009)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
Yukihiko Sonoda et al.
CANCER SCIENCE (2009)
Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model
Ken Matsumoto et al.
CANCER SCIENCE (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers
Mi Ran Kang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum
Susanne Schlisio
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
l-2-Hydroxyglutaric aciduria, a disorder of metabolite repair
E. Van Schaftingen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Diagnostic Use of IDH1/2 Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues
Craig Horbinski et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
H. J. Dubbink et al.
NEUROLOGY (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney
Jinu Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Inactivation of mitochondrial NADP+-dependent isocitrate dehydrogenase by hypochlorous acid
Sin Young Park et al.
FREE RADICAL RESEARCH (2008)
Expanding chemical biology of 2-oxoglutarate oxygenases
Christoph Loenarz et al.
NATURE CHEMICAL BIOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Small interfering RNA-mediated silencing of mitochondrial NADP+-dependent isocitrate dehydrogenase enhances the sensitivity of HeLa cells toward tumor necrosis factor-α and anticancer drugs
In Sup Kil et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Regulation of ionizing radiation-induced apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase
Jin Hyup Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion
Sarah M. Ronnebaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
S Lee et al.
CANCER CELL (2005)
Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism
HJ Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of NADP+-dependent isocitrate dehydrogenase (NADP+-ICDH) on cellular, defence against oxidative injury by γ-rays
SH Lee et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2004)
Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity
X Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells
I Shechter et al.
JOURNAL OF LIPID RESEARCH (2003)
Cellular defense against singlet oxygen-induced oxidative damage by cytosolic NADP(+)-dependent isocitrate dehydrogenase
SY Kim et al.
FREE RADICAL RESEARCH (2003)
NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in D-2-hydroxyglutaric aciduria
S Kölker et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Cytosolic NADP+-dependent isocitrate dehydrogenase status modulates oxidative damage to cells
SM Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Absence of post-translational aspartyl β-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia
JE Dinchuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cellular defense against UVB-induced phototoxicity by cytosolic NADP+-dependent isocitrate dehydrogenase
SH Jo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase
SH Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
分享论文
